Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    MAKTEK Eurasia 2026 to connect MENA buyers with advanced manufacturing

    August 20, 2026

    Next Level Aviation® Appoints Mike Fleener as Senior Vice President of Global Sales

    August 19, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Wall Street rises after Treasury expands debt buybacks
    • MAKTEK Eurasia 2026 to connect MENA buyers with advanced manufacturing
    • Next Level Aviation® Appoints Mike Fleener as Senior Vice President of Global Sales
    • WHO maps three-month path for Congo Ebola containment
    • Indonesia 6.1 earthquake rattles North Sumatra coast
    • DRC Ebola outbreak sets national death toll record
    • DRC malaria cases surpass 26 million in 2025
    • XCMG Accelerates Global Equipment Deliveries for Infrastructure and Mining Projects
    Maghreb DigestMaghreb Digest
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Maghreb DigestMaghreb Digest
    Home » Etihad achieves remarkable profitability and expansion during 2023
    Travel

    Etihad achieves remarkable profitability and expansion during 2023

    March 6, 2024
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email

    Etihad Airways, the national airline of the United Arab Emirates, has reported an impressive performance for the fiscal year 2023, showcasing a robust operating result of AED 1.4 billion (approximately $394 million). This success is attributed to a significant surge in passenger revenue, which rose by AED 4 billion (about $1.1 billion) year-on-year.

    Etihad achieves remarkable profitability and expansion during 2023

    Furthermore, the airline has made commendable strides in enhancing its operational efficiency, highlighted by a 7% reduction in unit costs excluding fuel, leading to an upturn in passenger business profitability. Throughout 2023, Etihad Airways demonstrated its resilience and growth by transporting 14 million passengers, marking a nearly 40% increase from the previous year. This surge underscores the sustained demand for air travel and the effectiveness of the airline’s expanding network, which now boasts an 86% load factor, up from 82% in 2022.

    Total revenue for the year reached a remarkable AED 20.3 billion (roughly $5.5 billion), an increase from AED 18.3 billion ($5.0 billion) in the preceding year. The expansion of the airline’s operations included the launch of 15 new destinations, such as Lisbon, Copenhagen, Kolkata, and Osaka, supported by a 14 aircraft increase in its operating fleet to accommodate a 30% growth in Available Seat Kilometres (ASKs). Significant achievements in 2023 also include the strengthening of Etihad’s balance sheet, with net leverage being reduced to 2.5x net debt to EBITDA from 5.0x in 2022.

    This improvement was driven by strong cash-flow generation and controlled capital expenditure, alongside better aircraft utilization and the reactivation of previously parked aircraft. The airline’s strategic reorganization, which focused on its core offerings and efficiency enhancements, played a pivotal role in this success. Notably, the passenger widebody fleet now consists of 78% new generation aircraft, underscoring Etihad’s commitment to operational efficiency and reduced emissions.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

    Related Posts

    Etihad sets December start for Abu Dhabi Gothenburg flights

    August 13, 2026

    South Korea tourism surplus reaches post-pandemic high

    August 10, 2026

    Spain begins temporary border checks for Italy arrivals

    August 10, 2026
    Latest News
    Business

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    Healthcare shares strengthen market gains
    Healthcare stocks provided another source of support during Wednesday’s session as several pharmaceutical shares recorded large gains. Moderna shares surged 177%, while Merck advanced 12.6% after the companies announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene with Keytruda following surgical removal of high-risk melanoma. The combination met its primary endpoint for recurrence-free survival. It also met a key secondary endpoint measuring survival without distant cancer spread.

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026

    Indonesia 6.1 earthquake rattles North Sumatra coast

    August 19, 2026

    DRC Ebola outbreak sets national death toll record

    August 17, 2026

    DRC malaria cases surpass 26 million in 2025

    August 17, 2026

    South Korea auto exports reach $6.24 billion in July

    August 14, 2026

    Total solar eclipse crosses Russian Arctic and Europe

    August 13, 2026
    © 2026 Maghreb Digest | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.